Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

18.37 -0.04 (-0.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
Strong core business growth was overshadowed in Q3 by an acquisition. 
Via The Motley Fool
FLGT FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
From The Law Offices of Frank R. Cruz
Via Business Wire
4 Analysts Have This to Say About Fulgent Genetics
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Upgrades 
Via Benzinga
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FLGT DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
NASDAQ:FLGT Investor Alert: Deadline on November 21, 2022 in Lawsuit Against Fulgent Genetics, Inc.
San Diego, CA -- (SBWIRE) -- 11/15/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 21, 2022 in the lawsuit filed for certain investors of Fulgent Genetics, Inc.... 
Via SBWire
Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Fulgent Genetics, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Reports Third Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Earnings Preview: Fulgent Genetics
Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Fulgent... 
Via Benzinga
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
A Look Into Healthcare Sector Value Stocks
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Medtronic, Palantir, Fulgent, and Yatsen and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
From Fulgent Genetics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS